HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
12.20
+0.04 (0.33%)
At close: Aug 14, 2026, 4:00 PM EDT
12.21
+0.01 (0.08%)
After-hours: Aug 14, 2026, 7:34 PM EDT
HUTCHMED (China) Market Cap
HUTCHMED (China) has a market cap or net worth of $2.18 billion as of August 14, 2026. Its market cap has decreased by -21.95% in one year.
Market Cap
2.18B
Enterprise Value
883.70M
1-Year Change
-21.95%
Ranking
Category
Stock Price
$12.20
ChartMarket Cap Chart
Since March 17, 2016, HUTCHMED (China)'s market cap has increased from $1.60B to $2.18B, an increase of 36.39%. That is a compound annual growth rate of 3.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 2.13B | -8.45% |
| Dec 31, 2025 | 2.33B | -7.42% |
| Dec 31, 2024 | 2.51B | -19.95% |
| Dec 29, 2023 | 3.14B | 22.75% |
| Dec 30, 2022 | 2.56B | -50.05% |
| Dec 31, 2021 | 5.12B | 19.79% |
| Dec 31, 2020 | 4.27B | 27.79% |
| Dec 31, 2019 | 3.34B | 8.92% |
| Dec 31, 2018 | 3.07B | -35.89% |
| Dec 29, 2017 | 4.79B | 195.91% |
| Dec 30, 2016 | 1.62B | 1.27% |
| Mar 17, 2016 | 1.60B | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Supernus Pharmaceuticals | 2.77B |
| Regencell Bioscience Holdings | 2.67B |
| Prestige Consumer Healthcare | 2.46B |
| BioCryst Pharmaceuticals | 2.44B |
| Bausch Health Companies | 2.43B |
| Amylyx Pharmaceuticals | 2.42B |
| Trulieve Cannabis | 1.84B |
| Perrigo Company | 1.78B |